Akero Therapeutics Inc. (AKRO)
Akero Therapeutics Max Pain By Strike
AKRO trades at $49.23, pinned near the near-term max pain of $50 expiring Sep 19, 2025 (27 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($30-$50), reflecting growing call interest at higher strikes. Key magnetic zone at 50 where 3 expirations converge.
Akero Therapeutics Max Pain By Expiry
Max pain for AKRO shows an upward trend from 30 to 50, suggesting bullish positioning in longer-dated options. The 44% spread signals divergent expectations across timeframes. Levels distributed around 49.23. Strong magnetic level at 50 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 50 | 0.77 (1.56%) |
| Oct 17, 2025 | 47.5 | -1.73 (-3.51%) |
| Nov 21, 2025 | 50 | 0.77 (1.56%) |
| Jan 16, 2026 | 30 | -19.23 (-39.06%) |
| Feb 20, 2026 | 50 | 0.77 (1.56%) |